Open AccessCorrection of Metabolic Disorders in Diabetic Nephropathy in Children and Adolescents
Author(s) -
O. Тerekhova,
Orozaly J. Uzakov
Publication year - 2020
Publication title -
bûlletenʹ nauki i praktiki
Language(s) - English
Resource type - Journals
ISSN - 2414-2948
DOI - 10.33619/2414-2948/56/14
Subject(s) - ursodeoxycholic acid , medicine , nephropathy , diabetic nephropathy , diabetes mellitus , drug , gastroenterology , disease , endocrinology , pharmacology
The article presents data on the use of the drug ursodeoxycholic acid (Ursosan) for hepatomegaly and fatty hepatosis in children with diabetic nephropathy. 40 children were examined. Material treated by variational statistics Statistica for Windows v. 6.0. Use of preparations of ursodeoxycholic acid in addition to the basic treatment results in a significant improvement of clinical symptoms and lipid metabolism in children, as well as a favorable course of the main disease. It was noted positive clinical dynamics when using this drug.